UMMS Affiliation
Department of Molecular, Cell and Cancer Biology; RNA Therapeutics Institute; Program in Molecular Medicine; Li Weibo Institute for Rare Diseases Research; Horae Gene Therapy Center; Department of Pediatrics; Graduate School of Biomedical Sciences
Publication Date
2021-04-09
Document Type
Article
Disciplines
Cancer Biology | Disease Modeling | Genetics and Genomics | Neoplasms | Therapeutics
Abstract
Prime editors (PEs) mediate genome modification without utilizing double-stranded DNA breaks or exogenous donor DNA as a template. PEs facilitate nucleotide substitutions or local insertions or deletions within the genome based on the template sequence encoded within the prime editing guide RNA (pegRNA). However, the efficacy of prime editing in adult mice has not been established. Here we report an NLS-optimized SpCas9-based prime editor that improves genome editing efficiency in both fluorescent reporter cells and at endogenous loci in cultured cell lines. Using this genome modification system, we could also seed tumor formation through somatic cell editing in the adult mouse. Finally, we successfully utilize dual adeno-associated virus (AAVs) for the delivery of a split-intein prime editor and demonstrate that this system enables the correction of a pathogenic mutation in the mouse liver. Our findings further establish the broad potential of this genome editing technology for the directed installation of sequence modifications in vivo, with important implications for disease modeling and correction.
Keywords
Gene therapy, Cancer genetics, CRISPR-Cas9 genome editing
Rights and Permissions
Copyright © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
DOI of Published Version
10.1038/s41467-021-22295-w
Source
Liu P, Liang SQ, Zheng C, Mintzer E, Zhao YG, Ponnienselvan K, Mir A, Sontheimer EJ, Gao G, Flotte TR, Wolfe SA, Xue W. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nat Commun. 2021 Apr 9;12(1):2121. doi: 10.1038/s41467-021-22295-w. PMID: 33837189; PMCID: PMC8035190. Link to article on publisher's site
Journal/Book/Conference Title
Nature communications
Related Resources
PubMed ID
33837189
Repository Citation
P, Liang S, Zheng C, Mintzer E, Zhao YG, Ponnienselvan K, Mir A, Sontheimer EJ, Gao G, Flotte TR, Wolfe SA, Xue W. (2021). Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Open Access Publications by UMass Chan Authors. https://doi.org/10.1038/s41467-021-22295-w. Retrieved from https://escholarship.umassmed.edu/oapubs/4699
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Included in
Cancer Biology Commons, Disease Modeling Commons, Genetics and Genomics Commons, Neoplasms Commons, Therapeutics Commons